PHARMACOKINETIC STUDY

Clinical trials for PHARMACOKINETIC STUDY explained in plain language.

Never miss a new study

Get alerted when new PHARMACOKINETIC STUDY trials appear

Sign up with your email to follow new studies for PHARMACOKINETIC STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Terminated 1

Could a lower dose of enzalutamide work better for elderly prostate cancer patients?

Knowledge-focused Not yet recruiting

This phase 2 trial is testing four different doses of enzalutamide (40, 80, 120, and 160 mg) in men aged 75 and older with advanced prostate cancer. The goal is to see how drug levels in the blood differ between older and younger patients, and to find the safest and most effectiv…

Matched conditions: PHARMACOKINETIC STUDY

Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:04 UTC

PHARMACOKINETIC STUDY

Get alerted when new PHARMACOKINETIC STUDY trials appear

Could a lower dose of enzalutamide work better for elderly prostate cancer patients?